Accessibility settings

This paper is in the following e-collection/theme issue:

Dermatology Health Services Research (72) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (232) Pharmacovigilance (185)

Published on in Vol 5, No 3 (2022): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39229, first published .
Hand holding colorful pills and glass of water, focus on medication

Photosensitivity From Avapritinib: Pharamacovigilance Analysis

Photosensitivity From Avapritinib: Pharamacovigilance Analysis

Authors of this article:

Ajit Venkatakrishnan1 Author Orcid Image ;   Brandon Chu2 Author Orcid Image ;   Pushkar Aggarwal3 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

Journals

  1. Barbieri M, Sorbara E, Russo G, Cicala G, Franchina T, Santarpia M, Silvestris N, Spina E. Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System. Cancers 2023;15(6):1851 View
  2. Thompson C, Andrews M, Adler D. A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications. Future Science OA 2026;12(1) View